DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
India, Jan. 3 -- CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
The Drug Controller General of India announced approval for the restricted emergency use of the novel coronavirus disease (COVID-19) vaccines manufactured by Bharat Biotech International Ltd and Serum Institute of India January 3, 2021. However, key questions about the efficacy results of the former remain unanswered.
VG Somani said the Central Drugs Standard Control Organisation (CDSCO) had accepted the recommendations made to it by the subject expert committee (SEC) appointed by the organisation January 1 and January 2.
The SEC had recommended emergency use of the SII-Astra/Oxford vaccine January 1, followed by B...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.